• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Merck & Co (MRK)

Common Stock
Sell: $87.50|Buy: $88.02|Change: 0.31 (0.36%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographicalperspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Address

126 East Lincoln Avenue
Rahway
NJ
USA
07065

Telephone

+1 732 5941468

Website

https://www.merck.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Merck & Co Inc Third Quarter Earnings Result for 20262026-10-29T00:00:00
Merck & Co Inc Third Quarter Earnings Conference Call for 20262026-10-29T00:00:00
Merck & Co Inc Second Quarter Earnings Result for 20262026-08-04T00:00:00
Merck & Co Inc Second Quarter Earnings Conference Call for 20262026-08-04T00:00:00
Merck & Co Inc Annual General Meeting for 20262026-05-27T09:00:00
Merck & Co Inc First Quarter Earnings Result for 20262026-04-30T00:00:00
Merck & Co Inc First Quarter Earnings Conference Call for 20262026-04-30T00:00:00
Merck & Co Inc Annual Report for 20252026-02-25T00:00:00
Merck & Co Inc Fourth Quarter Earnings Result for 20252026-02-03T00:00:00
Merck & Co Inc Fourth Quarter Earnings Conference Call for 20252026-02-03T00:00:00
Merck & Co Inc Third Quarter Earnings Conference Call for 20252025-10-30T09:00:00
Merck & Co Inc Third Quarter Earnings Result for 20252025-10-30T00:00:00

Previous key dates

NameKey Date
Merck & Co Inc Third Quarter Earnings Conference Call for 20252025-10-30T09:00:00
Merck & Co Inc Third Quarter Earnings Result for 20252025-10-30T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T14:35:00
Merck to Participate in the 2025 Wells Fargo Healthcare Conference2025-09-04T11:50:00
Merck & Co Inc Second Quarter Earnings Conference Call for 20252025-07-29T09:00:00
Merck & Co Inc Second Quarter Earnings Result for 20252025-07-29T00:00:00
46th Annual Goldman Sachs Global Healthcare Conference2025-06-10T10:00:00
Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference 20252025-05-29T15:30:00
Merck & Co Inc Annual General Meeting for 20252025-05-27T09:00:00
Bank of America 2025 Global Healthcare Conference2025-05-14T10:40:00
Merck & Co Inc First Quarter Earnings Conference Call for 20252025-04-24T09:00:00
Merck & Co Inc First Quarter Earnings Result for 20252025-04-24T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-03T14:30:00
Merck & Co Inc Annual Report for 20242025-02-25T00:00:00
Merck & Co Inc Fourth Quarter Earnings Conference Call for 20242025-02-04T09:00:00
Merck & Co Inc Fourth Quarter Earnings Result for 20242025-02-04T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T16:30:00
Merck to Participate in the Citi 2024 Global Healthcare Conference2024-12-05T08:00:00
Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference2024-12-03T13:20:00
Merck to Participate in the Jefferies London Healthcare Conference2024-11-21T11:30:00
Merck to Participate in the UBS Global Healthcare Conference2024-11-13T12:30:00
Merck & Co Inc Third Quarter Earnings Conference Call for 20242024-10-31T09:00:00
Merck & Co Inc Third Quarter Earnings Result for 20242024-10-31T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.